Breaking News
January 20, 2018 - MSU scientists seek to identify brain mechanisms related to psychosis
January 20, 2018 - Syndax Pharmaceuticals Announces Clinical Collaboration to Evaluate Entinostat in Combination with anti-PD-L1 Cancer Immunotherapy in Breast Cancer
January 20, 2018 - Endoscopes Over Microscopes in Retinal Surgery: Ophthalmology Times
January 20, 2018 - Technology not taking over children’s lives despite screen-time increase
January 20, 2018 - Study finds extensive contamination around lead battery recycling plants in 7 African countries
January 20, 2018 - Flu may pass to others through exhaled breath, study shows
January 20, 2018 - Neuronal loss very limited in Alzheimer’s disease, new study shows
January 20, 2018 - Novel robot can aid treatment of rare birth defect
January 19, 2018 - TherapeuticsMD Announces Submission of New Drug Application for TX-001HR
January 19, 2018 - Fighting Infant Mortality | Medpage Today
January 19, 2018 - Researchers offer new evidence on four-year-old children’s knowledge about ecology
January 19, 2018 - Analysis finds overlooked crucial factor in determining prognosis for DIPGs
January 19, 2018 - Review explores consequences of genetic testing and cancer risk-reducing surgery
January 19, 2018 - Morning Break: HHS Div. of Religious Freedom; Trump’s Heart Health; Minister of Loneliness
January 19, 2018 - Parkinson’s disease ‘jerking’ side effect detected by algorithm
January 19, 2018 - New analysis finds dramatic increases in maternal mortality rates
January 19, 2018 - Weight-Loss Surgery’s Benefits Wane Over Time for Diabetics
January 19, 2018 - Cath Lab Recap: Sapien 3 Delivery System Recall; Transatlantic PCI Smackdown
January 19, 2018 - Parkinson’s treatment could be more effective, student finds
January 19, 2018 - New vaccine approach offers effective protection against tuberculosis
January 19, 2018 - Home care agencies often wrongly deny Medicare help to the chronically ill
January 19, 2018 - One hundred percent fruit juice does not alter blood sugar levels
January 19, 2018 - Prebiotics could enhance learning and memory skills in infants
January 19, 2018 - CMS May Cover MRI With Cardiac Devices Across the Board
January 19, 2018 - As income rises, women get slimmer—but not men
January 19, 2018 - Researchers develop adhesive materials to prevent bracket stains on teeth
January 19, 2018 - Flu can be spread without coughs and sneezes
January 19, 2018 - AMSBIO’s new recombinant protein shows great promise for organoid culture
January 19, 2018 - AbbVie’s Upadacitinib Granted Breakthrough Therapy Designation from the U.S. Food and Drug Administration for Atopic Dermatitis
January 19, 2018 - ASH: Pomalidomide Dose Escalation Improves Response
January 19, 2018 - Is your child’s school an obesity risk?
January 19, 2018 - Scientists describe groundbreaking training effect on the innate immune system
January 19, 2018 - MAST announces new AmpC, ESBL & Carbapenemase Detection Set
January 19, 2018 - Signaling molecules likely involved in concussions, rodent studies show
January 19, 2018 - Mast introduces Carba plus for CPE and OXA-48 confirmation
January 19, 2018 - Paleolithic diet helps overweight women maintain weight loss
January 19, 2018 - Agios Submits New Drug Application to the FDA for Ivosidenib for the Treatment of Patients with Relapsed/Refractory AML and an IDH1 Mutation
January 19, 2018 - This Flu Season, Don’t Forget About Tamiflu
January 19, 2018 - Amsterdam wins battle to host EU medicines agency after Brexit
January 19, 2018 - Study suggests movement as accurate method to diagnose neurodevelopmental disorders
January 19, 2018 - Maximize resolution in deep imaging for neuroscience research with Olympus TruResolution objectives
January 19, 2018 - Bilingualism may benefit children with ASD
January 19, 2018 - FDA Alert: Levofloxacin in 5 Percent Dextrose 250mg/50mL by AuroMedics: Recall
January 19, 2018 - USPSTF Not Backing Ankle-Brachial Index, CRP, or Coronary Calcium
January 19, 2018 - Higher omega-3 fatty acid intake tied to lower glaucoma risk
January 19, 2018 - Findings reveal conventional cancer therapy as double-edged sword
January 19, 2018 - Health Highlights: Jan. 16, 2018
January 19, 2018 - Morning Break: Anti-Emetic Warning; Uninsured Rate Jumps; Flu Worsens Saline Shortage
January 19, 2018 - Increased use of ambulatory surgery centers for cataract surgery
January 19, 2018 - Not-for-profit hospitals coming up with their own generic medicines to combat shortages
January 19, 2018 - $500 cancer detection blood tests may soon become reality
January 19, 2018 - Chronic traumatic encephalopathy may start early even without signs of concussions
January 19, 2018 - Warm-up program for children cuts soccer injuries by 50%
January 19, 2018 - ‘You’re Old and You Need Tests’: What We Heard This Week
January 19, 2018 - Egg-preserving hysterectomy raises heart risks later: study
January 19, 2018 - GA-map Dysbiosis Test identifies IBS patients who respond to FODMAP diet, study shows
January 19, 2018 - Study explores mortality and health-related habits in former elite athletes and their brothers
January 19, 2018 - New biodegradable sensors could assist doctors
January 19, 2018 - Modular gene enhancers may be suitable target in treatment of blood cancer
January 18, 2018 - New precision medicine trial for metastatic pancreatic cancer
January 18, 2018 - Shire Receives FDA Breakthrough Therapy Designation for Maribavir, an Investigational Treatment for Cytomegalovirus (CMV) Infection in Transplant Patients
January 18, 2018 - Pre-Existing Patient-Valve Mismatch Trips Up ViV Implant
January 18, 2018 - Adolescents: health risks and solutions
January 18, 2018 - US woman delivers baby from embryo frozen for 24 years
January 18, 2018 - Study identifies new target for treatment of depression
January 18, 2018 - LJI study reveals key player that promotes skin inflammation in atopic dermatitis
January 18, 2018 - Study devises efficient and economical strategy to screen breast and ovarian cancer gene mutations
January 18, 2018 - Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla (AG200-15) for the Prevention of Pregnancy
January 18, 2018 - Gene Therapy for Inherited Retinal Dystrophy Gets FDA Clearance
January 18, 2018 - Researchers identify a new chemical pathway that helps the brain detect sweet, savory and bitter flavors
January 18, 2018 - IBV develops platform that helps companies to diagnose wellbeing of their workforce
January 18, 2018 - Study to test new precision medicine approach for metastatic pancreatic cancer
January 18, 2018 - World’s first vaccine relieves grass pollen allergy symptoms by at least 25%, study shows
January 18, 2018 - FDA Approves New Indication for Gilotrif (afatinib) in EGFR Mutation-Positive NSCLC
January 18, 2018 - Oncologists Dish on Top Issues for 2018
January 18, 2018 - Researchers identify new potential drug target for Huntington’s disease
January 18, 2018 - Metrohm USA welcomes employees to new headquarters in Florida
January 18, 2018 - Human waste remains main source of fecal pollution in the river Danube
January 18, 2018 - Expert discusses how to stay healthy during flu season
January 18, 2018 - New biomaterials-based system improves T-cell production
BRAF Mutation Status Tied to Papillary Thyroid Cancer Mortality

BRAF Mutation Status Tied to Papillary Thyroid Cancer Mortality

image_pdfDownload PDFimage_print

Action Points

  • Note that this observational study found that older age is a risk factor for aggressive papillary thyroid cancer, but only among those with BRAF V600E mutations.
  • With further confirmation, this may allow older individuals with wild-type BRAF thyroid cancer to avoid some of the most toxic therapies.

While age is a strong, and independent, mortality risk factor in papillary thyroid cancer (PTC) patients with BRAF V600E mutation, that is not the case in patients with wild-type BRAF, investigators have found in a retrospective study.

This finding challenges the long-held belief that the general use of patient age at diagnosis is a high-risk factor in PTC.

These findings were from a comparative study led by Xiaopei Shen, PhD, Johns Hopkins University School of Medicine in Baltimore, and published in the Journal of Clinical Oncology.

PTC is the most common type of thyroid cancer, accounting for >85% of all thyroid malignancies. As pointed out by Shen and his colleagues, risk stratification — based on clinicopathologic risk factors such as patient age — is an important component of standard management of thyroid cancer.

In fact, use of age as a major risk factor in thyroid cancer has been accepted since 1953, when a study in Annals of Surgery made the connection. And other studies have suggested that mortality in thyroid cancer goes up with increasing patient age.

“However, critical questions remain unanswered as to why older patient age has such a remarkable adverse effect on PTC-specific mortality and whether age is a risk factor universally applicable to all patients with PTC,” Shen and his colleagues wrote.

The investigators noted that the BRAF V600E mutation is known to be a main driver of PTC and is associated with older patient age and poor clinical outcomes. With this in mind they hypothesized that not only does BRAF V600E play an important role in the effect of patient age on PTC-specific mortality, but that in the absence of that mutation age may not be a risk factor.

To test that hypothesis Shen and his colleagues compared data on 2,638 patients (623 men and 2,015 women) with PTC from 11 medical centers in six countries. Patients had a median age of 46 (interquartile range 35-58), and a median follow-up of 58 months (IQR 26-107 months).

Shen and his colleagues found that after the age of 45 mortality rates increased as patient age increased overall — but the subgroup analysis by BRAF V600E mutation status showed the increase was entirely confined to those with the mutation.

And after adjusting for sex, tumor size, extrathyroidal extension, lymph node metastasis, distant metastasis, and administered activities of radioactive iodine, the linear relationship between PTC mortality and BRAF V600E remained, but was not seen in patients with wild-type BRAF.

These findings should have a major impact on the clinical management of PTC, the investigators suggested, considering the prevalence of BRAF V600E mutation in PTC is about 45%.

“As such, many older patients will be able to avoid more aggressive treatment that would otherwise be administered as a result of the conventional concept of older patient age being a general high-risk factor,” Shen and his colleagues wrote.

In an editorial accompanying the study, Megan Haymart, MD, of the University of Michigan in Ann Arbor, said that while the study’s findings provide insight into the relationship between age and thyroid cancer prognosis, the study was limited by the fact the authors only studied the absence or presence of one mutation.

“A necessary next step is evaluating age-related prognostication and other molecular markers, including evaluating the relationship between age, death, and coexistence of BRAF V600E and TERT promoter mutations,” she wrote.

She also pointed out that this study focused solely on papillary thyroid cancer. While that is the most common type of differentiated thyroid cancer, she noted that follicular thyroid cancer and Hürthle cell cancer are also staged by age.

Further studies are needed to confirm the concept of designing distinct staging systems on the basis of BRAF, “and whether our future staging systems will incorporate a molecular-based approach to risk stratification remains to be determined,” Haymart concluded. “Yet, this is a worthy area of investigation that offers potential opportunities to further tailor prognostication through a better understanding of pathogenesis.”

Supported by National Institutes of Health (NIH) Grants No. R01CA113507 and R01CA189224 (M.X.); Polish National Center of Research and Development MILESTONE Project Grant No. STRATEGMED2/267398/4/NCBR/2015 (Poland, A.C., B.J.); grants from Menzies Health Institute, Griffith University, Queensland Cancer Council and Queensland Smart State Fellowship (Australia; A.K.L.); Grants No. SAF2013-44709-R and SAF2016-75531-R (MINECO and FEDER), RD12/0036/0030, PI14/01980 (ISCIII), and GCB14142311CRES (AECC Foundation) (Spain; P.S. and G.R-E); Grants No. AZV 16-32665A and MH CZ-DRO (Institute of Endocrinology-EU, 00023761; Czech Republic; B.B., V.S.); grants from the New South Wales Cancer Institute (C.J.O.) and Cancer Council of New South Wales (Australia; R.C.-B.); NIH/National Institute on Aging Grant No. 5R03AG042334-02 (L.Y.); and grants from the Ministero della Istruzione Universitaria e Ricerca Scientifica, the Associazione Italiana per la Ricerca sul Cancro, the Istituto Toscano Tumori, and the Ministero della Salute (Italy; D.V., R.E.).

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

1969-12-31T19:00:00-0500

last updated

Tagged with:

About author

Related Articles